Literature DB >> 20485864

ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport.

Kai Yin1, Duan-fang Liao, Chao-ke Tang.   

Abstract

Atherosclerosis is characterized by a chronic inflammatory condition that involves numerous cellular and molecular inflammatory components. A wide array of inflammatory mediators, such as cytokines and proteins produced by macrophages and other cells, play a critical role in the development and progression of the disease. ATP-binding membrane cassette transporter A1 (ABCA1) is crucial for cellular cholesterol efflux and reverse cholesterol transport (RCT) and is also identified as an important target in antiatherosclerosis treatment. Evidence from several recent studies indicates that inflammation, along with other atherogenic-related mediators, plays distinct regulating roles in ABCA1 expression. Proatherogenic cytokines such as interferon (IFN)-γ and interleukin (IL)-1β have been shown to inhibit the expression of ABCA1, while antiatherogenic cytokines, including IL-10 and transforming growth factor (TGF)-β1, have been shown to promote the expression of ABCA1. Moreover, some cytokines such as tumor necrosis factor (TNF)-α seem to regulate ABCA1 expression in species-specific and dose-dependent manners. Inflammatory proteins such as C-reactive protein (CRP) and cyclooxygenase (COX)-2 are likely to inhibit ABCA1 expression during inflammation, and inflammation induced by lipopolysaccharide (LPS) was also found to block the expression of ABCA1. Interestingly, recent experiments revealed ABCA1 can function as an antiinflammatory receptor to suppress the expression of inflammatory factors, suggesting that ABCA1 may be the molecular basis for the interaction between inflammation and RCT. This review aims to summarize recent findings on the role of inflammatory cytokines, inflammatory proteins, inflammatory lipids, and the endotoxin-mediated inflammatory process in expression of ABCA1. Also covered is the current understanding of the function of ABCA1 in modulating the immune response and inflammation through its direct and indirect antiinflammatory mechanisms including lipid transport, high-density lipoprotein (HDL) formation and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20485864      PMCID: PMC2935947          DOI: 10.2119/molmed.2010.00004

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  139 in total

1.  Polyunsaturated fatty acids, inflammation, and cardiovascular disease: time to widen our view of the mechanisms.

Authors:  Frank M Sacks; Hannia Campos
Journal:  J Clin Endocrinol Metab       Date:  2006-02       Impact factor: 5.958

2.  HDL inflammation and atherosclerosis: current and future perspectives.

Authors:  Tiziana Sampietro; Federico Bigazzi; Mariarita Puntoni; Alberto Bionda
Journal:  Future Cardiol       Date:  2006-01

3.  Free cholesterol loading of macrophages induces apoptosis involving the fas pathway.

Authors:  P M Yao; I Tabas
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

4.  Platelet derived growth factor regulates ABCA1 expression in vascular smooth muscle cells.

Authors:  Sachi Nagao; Koji Murao; Hitomi Imachi; Wen-Ming Cao; Xiao Yu; Junhua Li; Kensuke Matsumoto; Takamasa Nishiuchi; Rania A M Ahmed; Norman C W Wong; Kazumitsu Ueda; Toshihiko Ishida
Journal:  FEBS Lett       Date:  2006-07-10       Impact factor: 4.124

5.  ATP-binding cassette transporter A1 (ABCA1) in macrophages: a dual function in inflammation and lipid metabolism?

Authors:  G Schmitz; W E Kaminski; M Porsch-Ozcürümez; J Klucken; E Orsó; M Bodzioch; C Büchler; W Drobnik
Journal:  Pathobiology       Date:  1999       Impact factor: 4.342

Review 6.  Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?

Authors:  B G Nordestgaard; J Zacho
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-08-19       Impact factor: 4.222

7.  TNFalpha induces ABCA1 through NF-kappaB in macrophages and in phagocytes ingesting apoptotic cells.

Authors:  Marie-Christine Gerbod-Giannone; Yankun Li; Adriaan Holleboom; Seongah Han; Li-Chung Hsu; Ira Tabas; Alan R Tall
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

8.  Aberrant inflammation and lethality to septic peritonitis in mice lacking STAT3 in macrophages and neutrophils.

Authors:  Akihiro Matsukawa; Kiyoshi Takeda; Shinji Kudo; Takako Maeda; Motoko Kagayama; Shizuo Akira
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

9.  High-density lipoprotein reduces the human monocyte inflammatory response.

Authors:  Andrew J Murphy; Kevin J Woollard; Anh Hoang; Nigora Mukhamedova; Roslynn A Stirzaker; Sally P A McCormick; Alan T Remaley; Dmitri Sviridov; Jaye Chin-Dusting
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-10       Impact factor: 8.311

10.  In-vivo effects of simvastatin and rosuvastatin on global gene expression in peripheral blood leucocytes in a human inflammation model.

Authors:  Wolfgang M Schmidt; Alexander O Spiel; Bernd Jilma; Michael Wolzt; Markus Müller
Journal:  Pharmacogenet Genomics       Date:  2008-02       Impact factor: 2.089

View more
  55 in total

Review 1.  Crosstalk between reverse cholesterol transport and innate immunity.

Authors:  Kathleen M Azzam; Michael B Fessler
Journal:  Trends Endocrinol Metab       Date:  2012-03-10       Impact factor: 12.015

Review 2.  The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids.

Authors:  Guo-Jun Zhao; Kai Yin; Yu-Chang Fu; Chao-Ke Tang
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

3.  Association of ATP-binding cassette transporter-A1 polymorphism with apolipoprotein AI level in Tehranian population.

Authors:  Sohrab Halalkhor; Seyed Alireza Mesbah-Namin; Maryam Sadat Daneshpour; Mehdi Hedayati; Fereidoun Azizi
Journal:  J Genet       Date:  2011-04       Impact factor: 1.166

4.  Transcriptome Analysis of K-877 (a Novel Selective PPARα Modulator (SPPARMα))-Regulated Genes in Primary Human Hepatocytes and the Mouse Liver.

Authors:  Sana Raza-Iqbal; Toshiya Tanaka; Motonobu Anai; Takeshi Inagaki; Yoshihiro Matsumura; Kaori Ikeda; Akashi Taguchi; Frank J Gonzalez; Juro Sakai; Tatsuhiko Kodama
Journal:  J Atheroscler Thromb       Date:  2015-06-04       Impact factor: 4.928

5.  Inhibition of Neuroinflammation by AIBP: Spinal Effects upon Facilitated Pain States.

Authors:  Sarah A Woller; Soo-Ho Choi; Eun Jung An; Hann Low; Dina A Schneider; Roshni Ramachandran; Jungsu Kim; Yun Soo Bae; Dmitri Sviridov; Maripat Corr; Tony L Yaksh; Yury I Miller
Journal:  Cell Rep       Date:  2018-05-29       Impact factor: 9.423

6.  Impact of alginate-producing Pseudomonas aeruginosa on alveolar macrophage apoptotic cell clearance.

Authors:  Charlie A McCaslin; Daniela N Petrusca; Gregory G Anderson; Irina Petrache; Christophe Poirier; Karina A Serban
Journal:  J Cyst Fibros       Date:  2014-07-12       Impact factor: 5.482

7.  AIBP augments cholesterol efflux from alveolar macrophages to surfactant and reduces acute lung inflammation.

Authors:  Soo-Ho Choi; Aaron M Wallace; Dina A Schneider; Elianne Burg; Jungsu Kim; Elena Alekseeva; Niki Dj Ubags; Carlyne D Cool; Longhou Fang; Benjamin T Suratt; Yury I Miller
Journal:  JCI Insight       Date:  2018-08-23

Review 8.  Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.

Authors:  Rai Ajit K Srivastava
Journal:  Mol Cell Biochem       Date:  2017-08-21       Impact factor: 3.396

9.  AIBP, inflammation, and atherosclerosis.

Authors:  Hainan Chen; Kai Yin
Journal:  J Lipid Res       Date:  2018-05-04       Impact factor: 5.922

10.  Vitamin D Protects Against Atherosclerosis via Regulation of Cholesterol Efflux and Macrophage Polarization in Hypercholesterolemic Swine.

Authors:  Kai Yin; Yong You; Vicki Swier; Lin Tang; Mohamed M Radwan; Amit N Pandya; Devendra K Agrawal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-09-17       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.